Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea - Our experience;Saccharomyces boulardii w profilaktyce biegunki zwizanej z antybiotykoterapia̧ - doświadczenia własne

Pediatria Polska

Volumn 87, Issue 1, 2012, Pages 14-18

  Czerwionka Szaflarska, Mieczysława ^a   Adamska, Inga ^a   Szaflarska Popławska, Anna ^a   Romańczuk, Bartosz ^a  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

diarrhea; prevention; Saccharomyces boulardii

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEFUROXIME; METRONIDAZOLE; PROBIOTIC AGENT;

ADOLESCENT; ANTIBIOTIC THERAPY; ARTICLE; CHILD; DISEASE DURATION; ERADICATION THERAPY; HELICOBACTER INFECTION; HUMAN; INFANT; LOOSE FECES; MAJOR CLINICAL STUDY; PRESCHOOL CHILD; RESPIRATORY TRACT INFECTION; SACCHAROMYCES BOULARDII; SCHOOL CHILD;

EID: 84857720838     PISSN: 00313939     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0031-3939(12)70589-9     Document Type: Article

References (17)

1. S. Pardo, M.A. Galvagno, and P. Cerrutti Studies of viability and vitality after freezing of the probiotic yeast Saccharomyces boulardii: physiological preconditioning effect Rev. Iberoam Micol 26 2009 155 160
2. I. Castagluolo, M.F. Riegler, and L. Valenick Saccharomyces boulardii protease inhibits effects of Clostridium difficile toxins A and B in human colonic mucosa Infect Immun 67 1999 302 307 (Pubitemid 29021663)
3. J.P. Buts Twenty-five years of research on Saccharomyces boulardii trophic effects: updates and perspectives Dig Dis Sci 54 2009 15 18
4. M. Czerwionka-Szaflarska, A. Dobrzańska, A. Chybicka, T. Jackowska, W. Lukas, and J. Ryko Stanowisko Grupy Ekspertów w sprawie profilaktyki biegunki zwizanej ze stosowaniem antybiotyków u dzieci Pediatr Pol 85 6 2010 604 608
5. J.G. Bartlett Clinical practise. Antibiotic-associated diarrhea N Engl J Med 346 2002 266 272
6. L.V. McFarland Antibiotic associated diarrhea: epidemiology, trends and treatment Future Microbiol 3 2008 563 578
7. S.H. Cohen, D.N. Gerding, S. Johnson, C.P. Kelly, V.G. Loo, and L.C. McDonald Clinical Practice Guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and hte infectious diseases society of America (IDSA) Infect Control Hosp Epidemiol of America (IDSA) 31 5 2010 431 455
8. B.C. Johnston, A.L. Supina, M. Ospina, and S. Vohra Probiotics for the prevention of pediatric antibiotic-associated diarrhea Cochrane Database Syst Rev 2 2007 CD004827
9. M. Ruszczyński, and H. Szajewska Probiotyki w zapobieganiu biegunce zwizanej ze stosowaniem antybiotyków - aktualizacja metaanalizy badań z randomizacj Pediatr Współcz 10 2 2008 96 104
10. L.V. McFarland Systematic review and meta-analysis of Saccharomyces boulardii in adult patients World J Gastroenterol 16 18 2010 2202 2222
11. D. Turck, J.P. Bernet, J. Marx, H. Kempf, P. Giard, and O. Walbaum Incidence and risk factors of oral antibiotic-associated diarrhea in an outpatient pediatric populationJ Pediatr Gastroenterol Nutr 37 1 2003 22 26 (Pubitemid 39274563)
12. J. Wiströma, S.R. Norrbyb, E.B. Myhreb, S. Erikssonc, and G. Granströmd Frequency of antibiotic-associated diarrhoea in 2462 antibiotic-treated hospitalized patients: a prospective study J. Antimicrob. Chemother 47 1 2001 43 50
13. M. Kotowska, P. Albrecht, and H. Szajewska Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea in children: a randomized double-blind placebocontrolled trial Aliment Pharmacol Ther 21 5 2005 583 590 (Pubitemid 40381510)
14. H. Szajewska, A. Horvath, and A. Piwowarczyk Meta-analysis: the effects of Saccharomyces boulardii supplementation on Helicobacter pylori eradication rates and side effects during treatment Alimentary Pharmacology Therapetics 32 2010 1069 1079
15. M. Cindoruk, G. Erkan, T. Karakan, A. Dursun, and S. Unal Efficacy and safety of Saccharomyces boulardii in the 14-day triple anti-Helicobacter pylori therapy: a prospective randomized placebo-controlled double-blind study Helicobacter 12 4 2007 309 316 (Pubitemid 47196340)
16. D.G. Duman, S. Bor, O. Ozutemiz, T. Sahin, D. Oguz, and F. Istan Efficacy and safety of Saccharomyces boulardii in prevention of antibiotic-associated diarrhea due to Helicobacter pylori eradication Eur J Gastroenterol Hepatol 17 2005 1357 1361 (Pubitemid 41830458)
17. Hurduc V, Plesca D, Dragomir D, Sajin M, Vandenplas Y. A randomized, open trial evaluating the effect of Saccharomyces boulardii on the eradication rate of Helicobacter pylori infection in children Acta Paediatrica, 98(1): 127-13.